MLH1 and cancer: Transcriptional silencing of hMLH1 (sporadic MSI-H); germline MMR gene mutations (Lynch Syndrome) High mutational burden, high frameshift mutation events, relatively lower SNV events compared to MSS; immune-related gene signatures, oncogenic and DNA repair pathways can be affected across MSI-H cancers